MedTrace Logo

Low-cost Sensor System for COVID-19 Patient Monitoring: Validation of BRAEBON Vital Signs Monitor (VTS)

NCT05029011 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2022-08-26

No results posted yet for this study

Summary

The BRAEBON VTS is a low-cost, portable device that is being developed to take continuous and real-time vital sign measurements of COVID-19 patients, both in the hospital and home setting. This study is being undertaken to test the BRAEBON VTS and validate against industry standards.

Conditions

Interventions

DEVICE

BRAEBON VTS

The BRAEBON VTS is a portable device that continuously monitors vital signs. Participants in the study will wear the BRAEBON VTS for 24 hours.

Sponsors & Collaborators

  • Braebon Medical Corporation

    collaborator UNKNOWN

  • National Research Council, Canada

    collaborator UNKNOWN

  • Helen S. Driver, PhD

    lead OTHER

Principal Investigators

  • Helen Driver, Phd · Queen's University and Kingston Health Sciences Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-07
Primary Completion
2022-07-15
Completion
2022-07-15

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05029011 on ClinicalTrials.gov